To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at For Technical questions please contact Thank you.

Privacy Policy Update

We remain dedicated to protecting your data and experience throughout our platforms. We have updated our Privacy Policy and your continued use of the Site means you have accepted the revised Privacy Policy. View now >


FAQ Home

Find Answers

EML4-ALK fusion validated
Has EML4-ALK fusion been validated in this isogenic cell line?

The EML4-ALK fusion variant 1 (E13; A20) in CCL-185IG has been extensively validated on both the genomic level and transcript level by sequencing. In addition, the expression of EML4-ALK fusion protein was verified by the Western blot method. This isogenic line has been shown to be more sensitive to ALK inhibitor, Crizotinib, when compared to its parental cell line (ATCC® CCL-185 ™) in cell-based assays.


Date Created01/18/2016 10:20 AM
Date Updated01/18/2016 10:21 AM

Most Popular Answers

  1. Huh7 cell line
  2. ATCC HUVEC lines
  3. Passage number vs. population doubling level (PDL)
  4. Converting TCID[50] to plaque forming units (PFU)
  5. U-373 MG (ATCC® HTB-17)